Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 13 for Polycythemia
  1. Polycythemia vera is a condition characterized by an increased number of red blood cells in the bloodstream. Affected individuals may also have excess white blood ...
  2. ... of tumors. Another form of acquired erythrocytosis, called polycythemia vera, results from somatic (non-inherited) mutations in ... signs and symptoms of the condition. Benign familial polycythemia Congenital erythrocytosis Familial polycythemia Hereditary erythrocytosis Primary familial ...
  3. ... of hypermanganesemia with dystonia, called hypermanganesemia with dystonia, polycythemia, and cirrhosis (HMDPC) and hypermanganesemia with dystonia 2, ...
  4. ... been identified in people with hypermanganesemia with dystonia, polycythemia, and cirrhosis (HMDPC, also known as hypermanganesemia with ... dystonia); an increased number of red blood cells (polycythemia); and liver abnormalities, including irreversible liver disease (cirrhosis). ...
  5. ... mutations in the JAK2 gene are associated with polycythemia vera, a disorder characterized by uncontrolled blood cell ... found in approximately 96 percent of people with polycythemia vera. About 3 percent of affected individuals have ...
  6. ... mutations in the TET2 gene are associated with polycythemia vera, a disorder characterized by uncontrolled blood cell ... found in approximately 16 percent of people with polycythemia vera. It is unclear what role these mutations ...
  7. ... of the disorder (for example, hypermanganesemia with dystonia , polycythemia vera , and cryptogenic cirrhosis ); The parts of the ...
  8. ... well as an excess of red blood cells (polycythemia) or deficiency of white blood cells (leukopenia) in ...
  9. ... RL. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia. 2009 May; ...
  10. ... RL. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia. 2009 May; ...
previous · 1 · 2 · next